| 1 |
Persistence of immunity against Omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination |
| 2 |
Pharmacokinetics of isoniazid and rifapentine in young paediatric patients with latent tuberculosis infection |
| 3 |
Validation of the NeuMoDx™ SARS-CoV-2 Assay with COPAN eNAT® and E&O Viral PCR Sample Solution (VPSS) collection media types in comparison with other validated SARS-CoV-2 RNA assays |
| 4 |
Colonization of the Newborn Respiratory Tract and Its Association with Respiratory Morbidity in the first six months of life: A Prospective Cohort Study |
| 5 |
Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study |
| 6 |
The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates – increased association of Klebsiella pneumoniae CC14 clone with Emirati patients |
| 7 |
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort |
| 8 |
Global respiratory virus surveillance: strengths, gaps, and way forward |
| 9 |
Toward Typhoid Fever Elimination |
| 10 |
Histiocytoid Sweet Syndrome associated with anorectal lymphogranuloma venereum in a patient with HIV infection |
| 11 |
In-vivo reflectance confocal microscopy in patients with chromoblastomycosis |
| 12 |
The show is not over – wild-type polio in Malawi is a wake-up call and an opportunity for elimination efforts |
| 13 |
Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children. |
| 14 |
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness |
| 15 |
The effect of ivermectin on the viral load and culture viability in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial |
| 16 |
How to (ab)use a COVID-19 antigen rapid test with soft drinks? |
| 17 |
Letter to the Editor: Failure to account for population size introduces spurious correlation for almost all diseases at a country level |
| 18 |
A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine |
| 19 |
Mast cell activation symptoms are prevalent in Long-COVID |
169463
